Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Turcot syndrome × camrelizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 40 Carcinoma, Non-Small-Cell Lung 31 Triple Negative Breast Neoplasms 23 Stomach Neoplasms 22 Nasopharyngeal Carcinoma 22 Esophageal Neoplasms 20 Esophageal Squamous Cell Carcinoma 19 Breast Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 14 Colorectal Neoplasms 12 Uterine Cervical Neoplasms 11 Sarcoma 10 Pancreatic Neoplasms 9 Lung Neoplasms 9 Recurrence 7 Neoplasm Metastasis 7 Melanoma 6 Liver Neoplasms 6 Hodgkin Disease 6 Cholangiocarcinoma 6 Biliary Tract Neoplasms 5 Advanced Gastric Cancer 5 Small Cell Lung Carcinoma 4 Osteosarcoma 4 Neoplasms 4 Locally Advanced Gastric Cancer 4 Advanced Solid Tumor 4 Solid Tumor 3 Respiratory Tract Diseases 3 Rectal Neoplasms 3

Interventions

pembrolizumab 10 Nivolumab 9 Ipilimumab 4 avelumab 3 Neoadjuvant Therapy 3 sintilimab 2 durvalumab 2 atezolizumab 2 Specimen Handling 2 Immune Checkpoint Inhibitors 2 toripalimab 1 tislelizumab 1 spartalizumab 1 relatlimab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 denileukin diftitox 1 danvatirsen 1 camrelizumab 1 XELOX 1 Taxes 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06215677 2025-09-05

NITDC

Peking Union Medical College Hospital

Phase NA Recruiting

Gastrointestinal

Turcot syndrome, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡